Newsletter

Tennis: Novak Djokovic gets into corona research and acquires company shares – Sport-Mix

This news comes as a surprise!

Novak Djokovic (34) has acquired 80 percent of the shares in the Danish biotech company QuantBioRes. The head of the company Ivan Loncarevic told the news agency ‘Reuters’.

Djokovic, who is not vaccinated, gets into corona research!

QuantBioRes wants to develop a medical treatment against Covid-19. Around eleven people are currently working on it in Denmark, Australia and Serbia. The company is developing a peptide that blocks the coronavirus from infecting human cells. Clinical trials are expected to start in the UK this summer.

When asked what the amount of Djokovic’s investment, which was made in June 2020, was, CEO Loncarevic refused to answer.

Djokovic was expelled from Australia on Sunday after days of legal battle. The (still) world number one wanted to take part in the Australian Open with a medical exemption without being vaccinated.

However, his visa had been canceled because Djokovic could not provide sufficient evidence for the special permit. The federal court in Melbourne declared the withdrawal of the visa to be legal, after which the Serb had to leave the country.

.

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending